ATS 2018 International Conference

Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma [Board No. 420]

Location: Board no. 420

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Robert Price

MSc
GlaxoSmithKline;GSK

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Ian Pavord

MD, DM
Nuffield Department of Medicine and Oxford NIHR BRC, University of Oxford;Oxford University Hospitals NHS Foundation Trust;University of Oxford

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

Rahul Shrimanker

MBBS
University of Oxford

Oliver N. Keene

MSc
GlaxoSmithKline

View Abstract

Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma

Parent Sessions

C101 - ASTHMA CLINICAL AND MECHANISTIC STUDIES...
05-22-2018 2:15 PM - 4:15 PM

Event